International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

The Review on Azithromycin

Author(s) Nandini Sanjay Gaikwad, Pooja B. Mairal
Country India
Abstract Azithromycin is broad spectrum macrolide antibiotic with long half life and excellent tissue penetration. Azithromycin is an azalide antimicrobial agent active in vitro major pathogens responsible for infectious of the respiratory tract, skin and soft tissue in children. In children azithromycin is usually given as either a 3- day course of 10 mg/kg/day on the first day,followed by 5 mg/kg/day for a further 4 days. Azithromycin is a subclass of microlide antibiotics. It is derived from erythromycin with a methyl–substituted nitrogen atom incorporated in lactone ring, thus making the lacctone ring 15-membered. Pathogen that are generally susceptible to azithromycin include Haemophilus influenzae (including ampicillin-resistant strains), Moraxella catarrhalis, Chalmydia pneumoniae, Chlamydia trachomatis, Mycoplasma pneumoniae Streptococcus pyogens and streptococcus agalactiae. Azithromycin is administerd once daily achieves clinically relevent concentration at sites of infection, is slowly eliminated from the body and has few drug interaction.A five day treatment administration (500 mg on day 1 followed by 250 mg on days 2-5 ) or a three day regimen (500 mg daily for three days).
Keywords Azalide, Macrolide, Infections
Field Medical / Pharmacy
Published In Volume 4, Issue 6, November-December 2022
Published On 2022-11-01
Cite This The Review on Azithromycin - Nandini Sanjay Gaikwad, Pooja B. Mairal - IJFMR Volume 4, Issue 6, November-December 2022. DOI 10.36948/ijfmr.2022.v04i06.947
DOI https://doi.org/10.36948/ijfmr.2022.v04i06.947
Short DOI https://doi.org/grb6c3
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com